The latest technology in treating mood disorders

Ketamine is an NMDA receptor antagonist that changes synaptic plasticity in a matter of hours.
Many Anti-depressant drug resistant patients see dramatic changes after the first treatment¹.

Sensorium Ketamine is located in New York City, across from Grand Central Station in Manhattan.

Learn more

Take back your life.

Ketamine has been clinically shown to be an effective therapy for depression, PTSD, chronic pain, neuropathic pain², and fibromyalgia.

At Sensorium Ketamine our broad certified anesthesiologists administers the treatment and monitor the patient during the entire therapy.

Is ketamine therapy right for me?

Find out more

Ketamine is a cutting edge treatment for drug resistent depression and pain management.
At Sensorium Ketamine Clinic, we provide a safe and effective treatment administered by board certified anesthesiologists.

Patients see change within hours.^3.

One hour dosing lasting up to 7 days.^3.

76% effective in providing pain relief.^4.

Endorsed by Department of Veteran Affairs.^5.

Location

Grand Central Station

Sensorium Ketamine Clinic is conveniently located near Grand Central Station in New York City.

Schedule a consultation

Finally

There is hope when all other treatments failed

Ketamine is a scientific breakthrough in treatment of pain and depression for patients with drug resistant mood disorders.

Pioneered by the US Military to treat PTSD⁵ researchers have uncovered benefits for treating other disorders which are published in peer reviewed journals.

Learn about ketamine

Refereces

"Ketamine: A Promising Novel Therapy for Anxiety and PTSD" Psychiatry Advisor. Yasgur, MA, LSW. March 2019 https://www.psychiatryadvisor.com/home/topics/anxiety/ketamine-a-promising-novel-therapy-for-anxiety-and-ptsd/
"Ketamine use in current clinical practice" Acta Pharmacologica Sinica. Mei Gao, et al. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4933765/
"A Review of Nonanesthetic Uses of Ketamine" Anesthesiology Research and Practice. Abby Pribish, Nicole Wood, Arun Kalava https://www.hindawi.com/journals/arp/2020/5798285/
"Ketamine for Treatment-Resistant Unipolar Depression" CNS Drugs. Mathew, S.J., Shah, A., Lapidus, K. et al. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3677048/
"VA to Offer New Ketamine-Based Nasal Spray for Depression" Military.com. Patricia Kime https://www.military.com/daily-news/2019/03/20/va-offer-new-ketamine-based-nasal-spray-depression.html